MML Investors Services
SUPN icon

MML Investors Services’s Supernus Pharmaceuticals SUPN Stock Holding History

MML Investors Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,318
Closed -$216K – 2573
2024
Q1 		$216K Buy
+6,318
New +$188K ﹤0.01% 2317
2023
Q1 		– Sell
-5,631
Closed -$201K – 2225
2022
Q4 		$201K Buy
+5,631
New +$196K ﹤0.01% 2029
2022
Q2 		– Sell
-6,493
Closed -$210K – 2139
2022
Q1 		$210K Sell
6,493
-787
-11% -$24.1K ﹤0.01% 1938
2021
Q4 		$212K Buy
+7,280
New +$221K ﹤0.01% 1895

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

MML Investors Services's SUPN Position: Q2 2024 in Review

MML Investors Services sold out of Supernus Pharmaceuticals (SUPN) in Q2 2024, closing a stake of 6,318 shares — an estimated $216K sold.

MML Investors Services first reported a position in SUPN in Q4 2021 and held it in 4 quarters. The position peaked at $216K in Q1 2024. 244 funds tracked by Wall St. Rank hold SUPN as of Q2 2024.

  • MML Investors Services reported no remaining Supernus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • MML Investors Services sold 6,318 Supernus Pharmaceuticals shares in Q2 2024, an estimated $216K.
  • MML Investors Services first reported a position in Supernus Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • MML Investors Services's Supernus Pharmaceuticals position peaked at $216K in Q1 2024.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2024.

Based on MML Investors Services's 13F filing for Q2 2024, filed 14 Aug 2024.